title: Question 2 Should phenytoin and carbamazepine be avoided in Asian populations with the HLA-B*1502 positive genetic variant?
authors.affiliation: Department of Paediatric Neurology, University Hospitals of Leicester NHS Trust, UK. priyasubbu2002@hotmail.com
authors.forename: Subramanian
authors.initials: S
authors.lastname: Ganesan
authors.forename: Nahin
authors.initials: N
authors.lastname: Hussain
mesh_terms: D000927:Anticonvulsants; D044466:Asian People / Q000235:genetics*; D002220:Carbamazepine; D002648:Child; D000075202:Contraindications; D003875:Drug Eruptions / Q000208:ethnology / Q000235:genetics*; D004827:Epilepsy / Q000188:drug therapy* / Q000208:ethnology; D019317:Evidence-Based Medicine; D015235:HLA-B Antigens / Q000235:genetics*; D059910:HLA-B15 Antigen; D006801:Humans; D010672:Phenytoin
chemical_list: D000927:Anticonvulsants; D015235:HLA-B Antigens; C483536:HLA-B*15:02 antigen; D059910:HLA-B15 Antigen; D002220:Carbamazepine; D010672:Phenytoin